Optimization of the EMIT Immunoassay Procedure for the Analysis of Cannabinoids in Methanolic Blood Extracts
- 1 July 1989
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Analytical Toxicology
- Vol. 13 (4) , 235-237
- https://doi.org/10.1093/jat/13.4.235
Abstract
EMIT assays are commonly used for the detection of cannabinoids in urine and have been widely adapted to accommodate blood samples. Over recent years, several different kits have been produced by the assay manufacturer for this purpose. The newest kit was found to be significantly less sensitive for methanolic blood extracts than kits previously available. Modifications are described to improve the sensitivity of the newer cannabinoid kit as applied to blood extracts. In addition, information is presented which demonstrates enhanced performance of this assay procedure by the use of a commercially available enzyme substrate supplement.This publication has 3 references indexed in Scilit:
- A Novel Procedure for the Analysis of Drugs in Whole Blood by Homogeneous Enzyme Immunoassay (EMIT®)Journal of Analytical Toxicology, 1988
- Direct Detection of Drugs of Abuse in Whole Hemolyzed Blood Using the EMIT d.a.u. Urine Assays*Journal of Analytical Toxicology, 1988
- GC/MS and EMIT Analyses for Δ9-Tetrahydrocannabinol Metabolites in Plasma and Urine of Human Subjects*Journal of Analytical Toxicology, 1986